Pfizer Says Three Shots Of Low-Dose Vaccine Generates ‘Strong Immune Response’ In Kids Under 5 Pfizer and BioNTech said they will finish submitting data to the FDA “this week” as they seek authorization for the shots, which aren’t yet available to children under 5.